Strain Profile
Save

Bifidobacterium pseudocatenulatum

◔ Human-origin
Sequenced
Public genome assembly available

Bifidobacterium pseudocatenulatum is a gram-positive anaerobic bacterium commonly found in the human gut microbiota and studied extensively in probiotic research. In vitro and animal studies have characterized its enzyme production (β-glucosidase, β-galactosidase, phytase), metabolic capabilities with dietary compounds (isoflavones, ellagic acid, flavonoids), synbiotic optimization with prebiotics, and its role in cholesterol metabolism, diet-induced obesity, and inflammation-related conditions studied via bile acid metabolism and the gut-bone and gut-joint axes. Research has examined multiple strains with varying functional properties. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 232 body-system-tagged papers that concern each system. Research coverage, not measured effect.

+4 more systems

Symptoms in the research

Share of this strain's 55 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

+11 more symptoms

Research

425 papers reference this strain in the probiotic database.

Match confidence
2026 ANIMAL
Bifidobacterium pseudocatenulatum extracellular vesicles promote Ly6G+ granulocyte infiltration to inhibit melanoma tumour progression
· bioRxiv (Cold Spring Harbor Laboratory)
2026 ANIMAL
Gut microbial histamine and serotonin promote cerebrovascular angiogenesis: Evidence from moyamoya disease
· Genes & Diseases
2026 ANIMAL
An infant-derived Bifidobacterium pseudocatenulatum DPU-MWF3-6 strain exhibits favorable in vitro functional properties and is well tolerated during early life in neonatal rats
· Food Bioscience
2026 ANIMAL
Bifidobacterium pseudocatenulatum AL44 ameliorates Enterococcus faecium-induced lung inflammation through NLRP3 suppression along the gut-lung axis
· Food Bioscience
2026 ANIMAL
Restoration of ethanol-induced Bifidobacterium pseudocatenulatum depletion ameliorates alcohol-associated liver disease
· npj Biofilms and Microbiomes
2026 OTHER
Bifidobacterium Pseudocatenulatum-Derived Metabolite C16 Overcomes ICB Resistance by Targeting Integrin α9 Signaling and Remodeling Macrophage–T Cell Crosstalk
· Mendeley Data
2025 ANIMAL
L‐Tryptophan Produced by Bifidobacterium pseudocatenulatum NCU‐08 Delays Aging in SAMP8 Mice by Activating the Sirt1/P53/P21/Rb Signaling Pathway
· Aging Cell
2025 ANIMAL
Bebida de soja enriquecida en lino mejora los efectos metabólicos de una dieta alta en grasa en un modelo de ratón
·
2025 IN_VITRO
Analysis of Novel Functional Enzymes Derived from Bifidobacteria that Degrade Acacia Senegal and A. Seyal Gum Arabic
· Bulletin of Applied Glycoscience
2025 IN_VITRO
Enhancement of Ellagic Acid Solubility and Bioaccesibility by Microencapsulation Process and Biotransformation to Urolithins
· Journal of Food Science
2025 OTHER
Safety evaluation of Bifidobacterium pseudocatenulatum E−0810 and its synbiotic formulation with xylooligosaccharides in alleviating LPS-induced inflammation in intestinal epithelial cells
· Food Bioscience
2025 IN_VITRO
A novel method for rapid detection of lactic acid bacteria resistance based on flow cytometry
· LWT
2025 ANIMAL
Fermented Lignan-Enriched Soy Beverage Ameliorates the Metabolic Effects of a High-Fat Diet on Female Mice
· Journal of Agricultural and Food Chemistry
2025 IN_VITRO
Exploring The Potential Adjuvant Role Of Bacterial Extracellular Vesicles Derived From Bifidobacterium Pseudocatenulatum Strains
· UEA Digital Repository (University of East Anglia)
2025 ANIMAL
Galactooligosaccharide-Metabolism-Related Genes of Bifidobacterium pseudocatenulatum Contribute to the Regulation of Glucose and Lipid Metabolism in Type 2 Diabetic Mice
· Journal of Agricultural and Food Chemistry
2025 OBSERVATIONAL
Varying Bifidobacterium species in the maternal-infant gut microbiota correlate with distinct early neurodevelopmental outcomes
· Journal of genetics and genomics/Journal of Genetics and Genomics
2025 IN_VITRO
Machine learning prediction of obesity-associated gut microbiota: identifying Bifidobacterium pseudocatenulatum as a potential therapeutic target
· Frontiers in Microbiology
2025 WGS
Genomic insights into the beneficial potential of Bifidobacterium and Enterococcus strains isolated from Cameroonian infants
· Microbial Genomics
2025 IN_VITRO
Importance of interaction between the matrix effect and microbial metabolism in the bioavailability of lignans
· Journal of the Science of Food and Agriculture
2024 WGS
Unveiling metabolic pathways of selected plant-derived glycans by Bifidobacterium pseudocatenulatum
· Frontiers in Microbiology
Browse all 425 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    Gut Bifidobacterium pseudocatenulatum protects against fat deposition by enhancing secondary bile acid biosynthesis
    · iMeta · 2024
    PMID 39742294 →
  2. [2]
    Selective human milk oligosaccharide utilization by members of the Bifidobacterium pseudocatenulatum taxon
    · Applied and Environmental Microbiology · 2024
    PMID 39315793 →
  3. [3]
    Bifidobacterium pseudocatenulatum capsular exopolysaccharide enhances systemic anti-tumour immunity in pre-clinical breast cancer
    · bioRxiv (Cold Spring Harbor Laboratory) · 2024
    Source →
  4. [4]
    Bifidobacterium pseudocatenulatum CECT 7765 supplementation improves inflammatory status in insulin-resistant obese children
    · European Journal of Nutrition · 2018
    PMID 30251018 →
  5. [5]
    Quantification of Folic Acid in Human Feces After Administration of Bifidobacterium Probiotic Strains
    · Journal of Clinical Gastroenterology · 2008
    PMID 18685499 →